Early research (Phase 1)Study completedNCT02171195
What this trial is testing
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
Who this might be right for
Epilepsy
Bial - Portela C S.A. 64